Selected article for: "asthma development and RV wheezing"

Author: Jartti, Tuomas; Smits, Hermelijn H.; Bønnelykke, Klaus; Bircan, Ozlem; Elenius, Varpu; Konradsen, Jon R.; Maggina, Paraskevi; Makrinioti, Heidi; Stokholm, Jakob; Hedlin, Gunilla; Papadopoulos, Nikolaos; Ruszczynski, Marek; Ryczaj, Klaudia; Schaub, Bianca; Schwarze, Jürgen; Skevaki, Chrysanthi; Stenberg-Hammar, Katarina; Feleszko, Wojciech
Title: Bronchiolitis needs a revisit: Distinguishing between virus entities and their treatments
  • Document date: 2018_11_25
  • ID: 4svg09dt_48
    Snippet: Maternal omega-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) and vitamin D supplementation in the third trimester of pregnancy may reduce the risk of persistent wheeze/asthma and respiratory infections in offspring ( Figure 5 ). 93, 94 Secondary prevention strategies of asthma aim at avoiding the development of allergic disease/asthma in already sensitized or wheezing subjects. 95 Thus far, allergen immunotherapy remains as the only treatm.....
    Document: Maternal omega-3 long-chain polyunsaturated fatty acid (n-3 LCPUFA) and vitamin D supplementation in the third trimester of pregnancy may reduce the risk of persistent wheeze/asthma and respiratory infections in offspring ( Figure 5 ). 93, 94 Secondary prevention strategies of asthma aim at avoiding the development of allergic disease/asthma in already sensitized or wheezing subjects. 95 Thus far, allergen immunotherapy remains as the only treatment available for modifying the course of allergic disease. 96 However, although in a recent study grass pollen immunotherapy was shown to reduce asthma-like symptoms in children, it did not decrease the development of asthma. 97 Interestingly, though, a systemic anti-inflammatory treatment of the first RV-induced severe wheezing episode markedly decreased the subsequent risk of asthma ( Figure 5) , (see section 7). [74] [75] [76] [77] Also, a

    Search related documents:
    Co phrase search for related documents
    • allergic disease and asthma subsequent risk: 1
    • allergic disease and fatty acid: 1
    • allergic disease and respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • allergic disease and subsequent risk: 1
    • allergic disease and wheeze asthma: 1
    • allergic disease asthma and asthma development: 1, 2, 3, 4, 5, 6, 7, 8
    • allergic disease asthma and fatty acid: 1
    • allergic disease asthma and respiratory infection: 1, 2
    • allergic disease asthma and wheeze asthma: 1
    • allergic disease asthma development and asthma development: 1, 2, 3
    • allergic disease asthma development and respiratory infection: 1